Life Science Analytics Market: Growth, Size, Share, and Trends

Report Code HIT 4869
Published in Oct, 2024, By MarketsandMarkets™
Download PDF

Choose License Type

Buy Report Now Inquire Before Buying

Life Science Analytics Market by Type (Descriptive, Prescriptive, Predictive), Service (Analytics), Application (Drug Discovery, Trials, RWE, Access, Sales & marketing, Drug Safety), End User (Pharma, Medical Device), & Region - Global Forecast to 2029

Overview

The global life science analytics market is expected to reach USD 61.94 billion by 2029 from USD 35.69 billion in 2024, at a CAGR of 11.7% during the forecast period. The standardization of diverse datasets (generated from sources like clinical trials, electronic health records, genomics, and real-world evidence) to exchange of information across various platforms & geographical regions, the emergence of technologies like AI, quantum computing, and cognitive computing that harness large volumes of raw data into actionable insights, simplifying reports, and creating interactive dashboards, and the rising adoption of analytics in preclinical trials, drug discovery, and clinical trials are some of the prominent factors that contribute to the constantly increasing adoption of analytics across the life sciences industry.

Attractive Opportunities in the Life Science Analytics Market

Asia Pacific

Market growth in the Asia Pacific can be attributed to presence of a large and growing patient population, an increasing need for innovative therapies, the emergence of big data in healthcare, and increasing spending on HCIT infrastructure.

Technological advancements in analytical solutions, rising need for improved data standardization, and the growing adoption of analytical solutions in clinical trials are key factors driving the market growth.

Utilization of analytics in precision & personalized medicine and growing adoption of cloud-based analytics solutions are factors expected to provide lucrative opportunities for market players.

The European life science analytics market is expected to be worth USD 19.6 billion by 2029, growing at CAGR of 11.7% during the forecast period.

Issues associated with data integration and shortage of skilled personnel are expected to pose a challenge to the growth of this market.

Global Life Science Analytics Market Dynamics

Drivers: Technological advancements in analytical solutions

Technological advancements in analytics solutions help users simplify reports and create interactive dashboards that enable easy access & translation of vast volumes of raw data into actionable insights. In addition, with the constantly changing needs of pharma & biopharma companies and the growing focus on research & development, there is a surging demand for enhanced advanced analytics tools capable of handling these changing requirements. New technologies such as cognitive computing help address challenges such as harnessing large-volume data, integrating data from hundreds of sources, and understanding various data formats. Key companies in the analytic market are investing in organic & inorganic strategies to leverage technologically sophisticated solutions in their life cycles & operations. For example, TetraScience partnered with Databricks in May 2024 to advance Scientific Al in life sciences and accelerate the development of effective and safer therapies. Trinity Life Sciences and Whizal also partnered in the same month to enable companies to quickly generate and share Al-driven insights by integrating WhizAl’s conversational Al and visualization platform with Trinity’s advanced data management solutions and advisory services.

Restraints: Data privacy concerns

The number of databases shared among research institutions, CROS, partners, and software companies has increased the risk of exposing sensitive patient information to undesired individuals. The US HITECH Act states that covered entities must protect individual health records and other identifiable health information by acquiring appropriate safeguards to protect privacy. The application of electronic tools for patient databases increases concerns regarding the safety and confidentiality of data. This creates a key challenge for pharmaceutical enterprises in complying with privacy policies using analytics solutions. Per IBM Security in 2022, the average cost of a mega breach increased to USD 241 million in 2022, compared to USD 230 million in 2021, demonstrating a growth of 4.8%. The IBM-Ponemon Institute’s Cost of a Data Breach Report (2021) estimated the total data breach cost in 2021 to be USD 4.24 million, up from USD 3.86 million in 2020.

 

Opportunities: Use of analytics in precision & personalized medicine

Data analytics in precision medicine aids in patient diagnosis, biomarker discovery, prognosis, and disease subtyping. It can combine vast amounts of data from multi-omics, EHRs, and wearable & implantable devices in real-time for accurate analysis. Precision medicine uses genomic data to develop personalized medicine. Advanced analytics and predictive modeling applications can enable organizations to tailor treatments to patients’ needs. Analytics has been used to help streamline this process; its potential has caught the attention of several stakeholders in the market. In January 2023, Caris Life Sciences, a molecular science and technology company, raised USD 1.7 billion in funding to advance its capabilities in precision medicine, particularly in molecular profiling and targeted therapies.

Challenge: Shortage of skilled professionals

Skilled labor is becoming an important talking point for this market. The complexity of technologies included in or related to analytics, such as AI, ML, and big data management, translates into a growing demand for well-educated and experienced specialists. However, the limited availability of talent with the right blend of technical and domain expertise is slowing the adoption and development of analytics. Not many organizations can claim to have sufficient in-house expertise; a report published by Randstad Sourceright’s 2022 Talent Trends reported that 33% of C-suite & human capital leaders in the life sciences & pharma sectors brought up talent scarcity as a challenge to growth.

Addressing this talent gap requires a multi-faceted approach, including investment in training and education, industry-academic partnerships, and integrating user-friendly analytics tools.

Global Life Science Analytics Market Ecosystem Analysis

The ecosystem of the life science analytics market comprises investors, academic researchers & organizations, government and regulatory bodies, key players, startups, the life science industry, pharmaceutical & biotechnology companies, medical device companies, research centers, and outsourced life science organizations (CROs, CMOs, independent contractors, etc). The ecosystem also includes enablers such as data source providers, ERP providers, business intelligence and analytical tool providers, cloud service providers, web interface and application developers, network connectivity providers, security and privacy solutions providers, hardware providers, and consultants.

Source: Secondary Literature, Interviews with Experts, and MarketsandMarkets Analysis

 

Descriptive analytics segment accounted for a substantial share of the life science analytics market, by type in 2023.

Descriptive analytics is the dominant segment in the life science analytics market. Its large share is supported by the growing data generated from clinical trials, patient records, & research studies, the emphasis on real-world data, and demands for data-driven decision-making. This form of analytics helps identify trends, measure performance, and facilitate collaboration, helping researchers with limited data science experience meet regulatory & market demands for clear, actionable insights. It also allows companies to find bottlenecks in supply chains and adjust production. The versatility of descriptive analytics will ensure growth opportunities in the coming years. These factors collectively drive the expansion of descriptive analytics, fostering innovation in the life sciences sector.

Commercial analytics is expected to register the highest growth in the life science analytics market, by application

In 2023, commercial analytics is expected to register the highest growth in the life science analytics market by application during the forecast period. The surging uptake of advanced analytics solutions by life science companies to align sales and marketing campaigns and the growing importance of post-marketing surveillance drive market growth. Advancements in technology, such as artificial intelligence (AI) and machine learning drive better and more efficient data processing and predictive modeling, contributing to the rapid expansion of commercial analytics capabilities. For instance, in November 2023, Axtria (US) launched Axtria DataMAX Emerging Pharma, an Al-enabled SaaS solution designed to help small and emerging biotech and pharmaceutical companies make data-driven decisions, streamline commercialization, and scale efficiently.

North America dominated the life science analytics market in 2023.

The life science analytics market is studied for the five major regions: North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. The North American region dominated the life science analytics market owing to factors such as the region’s high per-capita healthcare expenditure, ongoing developments in technologies, particularly in big data, artificial intelligence (AI), & cloud computing, rising demand for personalized medicine driven by genomic data and patient-centric approaches, and the growing importance of analytics in R&D, sales, marketing, and supply chain optimization. The growing focus on quality control, regulatory compliance, developed healthcare & life sciences infrastructure, and the surging demand for digitalized technologies across North America further propels the growth. Moreover, the competitive landscape in North America encourages innovation among market players, driving continuous growth in technology and service offerings by various market vendors.

HIGHEST CAGR MARKET IN 2023
US FASTEST GROWING MARKET IN THE REGION

Recent Developments of Life Science Analytics Market

  • In July 2024, Indegene partnered with Microsoft to scale generative AI adoption in life sciences, enhancing innovation and efficiency across the industry.
  • In June 2024, SAS launched its analytics platform - SAS Clinical Acceleration Repository, to streamline clinical trial development, expedite the regulatory submission process, control data from clinical research, and interface with several data sources.
  • In June 2024, IQVIA launched the One Home for Sites platform to streamline clinical trial management by consolidating multiple systems into a single dashboard, reducing the administrative burden on research sites.
  • In March 2024, Cognizant collaborated with NVIDIA to leverage the BioNeMo generative AI platform for accelerated drug discovery, aiming at higher productivity with reduced development expense in life sciences.
  • In November 2023, Wipro and AWS announced efforts to launch “Lab of the Future,” a cloud-based platform designed to streamline laboratory processes in life sciences using generative AI and advanced analytics. This will be done by reducing costs and improving efficiencies with accelerated drug development.

Key Market Players

KEY PLAYERS IN THE LIFE SCIENCE ANALYTICS MARKET INCLUDE

Want to explore hidden markets that can drive new revenue in Life Science Analytics Market?

Scope of the Report

Report Metric Details
Market size available for years 2022–2029
Base year considered 2023
Forecast period 2024-2029
Forecast units Million/Billion (USD)
Segments covered Type, Component, Application, and End User
Geographies covered North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

 

Key Questions Addressed by the Report

Which are the top industry players in the global Life science analytics market?
The top market players in the global Life science analytics market include Oracle (US), Merative (formerly IBM) (US), SAS Institute (US), Accenture (Ireland), IQVIA (US), Cognizant (US), Wipro (India), Veradigm (US), Optum (US), Microsoft (US), MaxisIT (US), ExlService Holdings (US), Inovalon (US), CitiusTech (US), Saama (US), Axtria (US), Clarivate (UK), ThoughtSphere (US), ThoughtSpot (US), Salesforce (US), Google LLC (US), Amazon Web Services, Inc. (US), Veeva Systems (US), Elsevier (Netherlands), and Komodo Health, Inc. (US).
Which components have been included in the Life science analytics market report?
This report contains the following components:
  • Software
  • Services
Which region dominates the global life science analytics market?
The global Life science analytics market is further bifurcated into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. North America holds a substantial share, and the Asia Pacific registers the highest growth rate during the forecast period.
Which end users have been included in the life science analytics market report?
The report contains the following industry segments:
  • Pharmaceutical & Biotechnology Companies
  • Medical Device Companies
  • Research Centers
  • Outsourced Life Science Organizations
What is the total CAGR expected to be recorded for the Life science analytics market during 2024-2029?
The market is expected to record a CAGR of 11.7% from 2024 –2029.

 

Personalize This Research

  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
Request A Free Customisation

Let Us Help You

  • What are the Known and Unknown Adjacencies Impacting the Life Science Analytics Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
Customized Workshop Request

Table of Contents

Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TITLE
PAGE NO
INTRODUCTION
36
RESEARCH METHODOLOGY
41
EXECUTIVE SUMMARY
55
PREMIUM INSIGHTS
59
MARKET OVERVIEW
62
  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    DRIVERS
    - Rising pressure to curb healthcare spending
    - Need for improved data standardization
    - Technological advancements in analytical solutions
    - Heterogeneity and complexity of big data in life sciences
    - Growing adoption of analytical solutions in clinical trials
    - Increasing R&D expenditure in pharmaceutical & biotechnology companies
    RESTRAINTS
    - High implementation costs of advanced analytical solutions
    - Data privacy concerns
    OPPORTUNITIES
    - Growing focus on value-based care
    - Use of analytics in precision & personalized medicine
    - Big data analytics for R&D productivity
    - Growing adoption of cloud-based analytics
    CHALLENGES
    - Issues associated with data integration
    - Shortage of skilled personnel
    - Reluctance to adopt life science analytics solutions in emerging countries
  • 5.3 INDUSTRY TRENDS
    GROWING ADOPTION OF ANALYTICS IN COMMERCIAL OPERATIONS
    LEVERAGING DATA & ANALYTICS TO ACCELERATE DRUG DISCOVERY & DEVELOPMENT
    FOCUS ON REAL-TIME DATA ANALYTICS
  • 5.4 TECHNOLOGY ANALYSIS
    KEY TECHNOLOGIES
    - Artificial intelligence and machine learning
    - Big data analytics
    - Quantum computing
    COMPLEMENTARY TECHNOLOGIES
    - Bioinformatics tools
    - Internet of things
    ADJACENT TECHNOLOGIES
    - Blockchain
  • 5.5 ECOSYSTEM ANALYSIS
  • 5.6 VALUE CHAIN ANALYSIS
  • 5.7 PORTER’S FIVE FORCES ANALYSIS
    THREAT OF NEW ENTRANTS
    THREAT OF SUBSTITUTES
    BARGAINING POWER OF SUPPLIERS
    BARGAINING POWER OF BUYERS
    INTENSITY OF COMPETITIVE RIVALRY
  • 5.8 KEY STAKEHOLDERS AND BUYING CRITERIA
    KEY STAKEHOLDERS IN BUYING PROCESS
    BUYING CRITERIA
  • 5.9 CASE STUDY ANALYSIS
    NOVARTIS USES MULTI-CLOUD DATA ANALYTICS PLATFORM TO OPTIMIZE OPERATIONS AND ACCELERATE INNOVATION
    SAS VISUAL ANALYTICS HELPS MAXIMIZE PROFITABILITY THROUGH PRESCRIPTIVE ANALYTICS & DATA VISUALIZATION
    STREAMLINING REGULATORY MONITORING AND IMPACT ASSESSMENTS: GEDEON RICHTER’S PARTNERSHIP WITH CLARIVATE
  • 5.10 REGULATORY LANDSCAPE
    REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    NORTH AMERICA
    EUROPE
    ASIA PACIFIC
    MIDDLE EAST & AFRICA
    LATIN AMERICA
  • 5.11 PRICING ANALYSIS
    AVERAGE SELLING PRICE OF KEY PLAYERS, BY APPLICATION
    AVERAGE SELLING PRICE, BY REGION
  • 5.12 KEY CONFERENCES AND EVENTS, 2024–2025
  • 5.13 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
  • 5.14 PATENT ANALYSIS
    PATENT PUBLICATION TRENDS
    JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES
    MAJOR PATENTS
  • 5.15 END-USER ANALYSIS
    UNMET NEEDS
    END-USER EXPECTATIONS
  • 5.16 LIFE SCIENCE ANALYTICS BUSINESS MODELS
    SUBSCRIPTION-BASED MODEL
    SAAS MODEL
    PAY-PER-USE/USAGE-BASED MODEL
    ENTERPRISE LICENSING
    FREEMIUM MODEL
    ENTERPRISE LICENSING
    CONCURRENT LICENSING
    CONSULTING SERVICES MODEL
    PARTNERSHIP/REVENUE-SHARING MODEL
    - Hybrid Models
  • 5.17 INVESTMENT & FUNDING SCENARIO
  • 5.18 IMPACT OF AI/GENERATIVE AI ON LIFE SCIENCE ANALYTICS MARKET
    TOP USE CASES & MARKET POTENTIAL
    - Key use cases
    CASE STUDIES OF AI/GENERATIVE AI IMPLEMENTATION
    - Case Study 1: Knowledge Mining for a Global Biopharmaceutical Company
    - Healthcare analytics market
    USER READINESS AND IMPACT ASSESSMENT
    - User readiness
    - Impact assessment
LIFE SCIENCE ANALYTICS MARKET, BY TYPE
116
  • 6.1 INTRODUCTION
  • 6.2 DESCRIPTIVE ANALYTICS
    ADVANCED VISUAL DATA EXPLORATION AND SUPPORT FOR INNOVATION TO DRIVE DEMAND
  • 6.3 PREDICTIVE ANALYTICS
    SIMULATION DEVELOPMENT FOR PREDICTING FUTURE TRENDS TO PROPEL MARKET GROWTH
  • 6.4 PRESCRIPTIVE ANALYTICS
    REAL-TIME ANALYSIS FOR IMPROVED DECISION-MAKING TO SUPPORT MARKET GROWTH
LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT
122
  • 7.1 INTRODUCTION
  • 7.2 SERVICES
    MANAGED SERVICES
    - Analytical services
    - Consulting services
    PROFESSIONAL SERVICES
    - Training & implementation
    - Maintenance & support services
    - Other professional services
  • 7.3 SOFTWARE
    ON-PREMISE SOLUTIONS
    - Provision of multivendor architecture and security benefits to drive market
    CLOUD-BASED SOLUTIONS
    - Real-time analysis and elimination of purchasing costs for software & hardware to drive adoption
    SAAS-BASED SOLUTIONS
    - Increasing adoption of digital solutions and advantages of cloud-based models to drive growth
LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION
138
  • 8.1 INTRODUCTION
  • 8.2 RESEARCH & DEVELOPMENT
    CLINICAL TRIALS
    - Life science analytics market for clinical trials, by type
    - Life science analytics market for clinical trials, by phase
    PRECLINICAL & DRUG DISCOVERY
    - Ability to assist researchers in process innovation and decision support to drive adoption
  • 8.3 COMMERCIAL ANALYTICS
    SALES & MARKETING SUPPORT
    - Rising analysis of digital marketing effectiveness to drive adoption
    MARKET ACCESS
    - Focus on strategic pricing, reimbursement, and policy changes to support market growth
    RWE & VALUE EVIDENCE
    - Increased data integration, partnerships, and technological to propel use of RWE
    ENGAGEMENT SERVICES
    - Need for better patient engagement, digital advancements, and AI integration to propel market
  • 8.4 REGULATORY COMPLIANCE
    STRINGENT REQUIREMENTS FOR COMPLIANCE ADHERENCE TO DRIVE ADOPTION
  • 8.5 MANUFACTURING & SUPPLY CHAIN OPTIMIZATION
    RISING NEED FOR REDUCING LOGISTICS COSTS TO SUPPORT MARKET GROWTH
  • 8.6 SAFETY
    PHARMACOVIGILANCE
    - Monitoring of drug trials and medication programs to fuel market uptake
    MEDICAL DEVICE SAFETY
    - Stringent safety standards, rigorous risk assessments, and robust quality control to drive demand
    DIAGNOSTIC VIGILANCE
    - Continuous monitoring, integration of diverse data sources, and ongoing education to enhance accuracy and thoroughness
LIFE SCIENCE ANALYTICS MARKET, BY END USER
168
  • 9.1 INTRODUCTION
  • 9.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
    RISING NEED FOR INNOVATIVE THERAPIES TO DRIVE ANALYTICS USAGE IN PRODUCT DEVELOPMENT
  • 9.3 MEDICAL DEVICE COMPANIES
    ADOPTION OF DATA ANALYTICS FOR DEVICE COMMERCIALIZATION TO DRIVE MARKET
  • 9.4 RESEARCH CENTERS
    NEED FOR ANALYZING LARGE VOLUMES OF DATA TO SUPPORT MARKET GROWTH
  • 9.5 OUTSOURCED LIFE SCIENCE ORGANIZATIONS
    RISING R&D OUTSOURCING BY LIFE SCIENCE COMPANIES TO DRIVE MARKET
    LIFE SCIENCE ANALYTICS MARKET, BY REGION
LIFE SCIENCE ANALYTICS MARKET, BY REGION
174
  • 10.1 INTRODUCTION
  • 10.2 NORTH AMERICA
    NORTH AMERICA: MACROECONOMIC OUTLOOK
    US
    - Established economy and increasing R&D expenditure to drive adoption of analytical solutions
    CANADA
    - Rising need for data standardization in life sciences to fuel uptake
  • 10.3 EUROPE
    MACROECONOMIC OUTLOOK FOR EUROPE
    GERMANY
    - Growing R&D investments by pharmaceutical & biotechnology companies to drive market
    FRANCE
    - Growing government support for adoption of AI & big data analytics to drive market
    UK
    - Rising clinical trial activity to drive uptake of life science analytics solutions
    ITALY
    - Growing number of drug approvals to drive uptake of analytics solutions
    SPAIN
    - Surging government investments focusing on personalized medicine to drive growth
    REST OF EUROPE
  • 10.4 ASIA PACIFIC
    ASIA PACIFIC: MACROECONOMIC OUTLOOK
    JAPAN
    - Growing government support for clinical R&D activities to drive adoption
    CHINA
    - Growth in life science industry to support adoption of solutions
    INDIA
    - Rising R&D expenditure and drug development to support market growth
    REST OF ASIA PACIFIC
  • 10.5 LATIN AMERICA
    LATIN AMERICA: MACROECONOMIC OUTLOOK
    BRAZIL
    - Brazil to dominate life science analytics market in Latin America
    MEXICO
    - Growing prominence of startups and rising R&D activity to propel market
    REST OF LATIN AMERICA
  • 10.6 MIDDLE EAST & AFRICA
    MIDDLE EAST & AFRICA: MACROECONOMIC OUTLOOK
    GCC COUNTRIES
    - Rising investments, advancements, and developing healthcare infrastructure to drive market
    REST OF MIDDLE EAST & AFRICA
COMPETITIVE LANDSCAPE
288
  • 11.1 OVERVIEW
  • 11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
    OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN LIFE SCIENCE ANALYTICS MARKET
  • 11.3 REVENUE ANALYSIS
  • 11.4 MARKET SHARE ANALYSIS
  • 11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
    STARS
    EMERGING LEADERS
    PERVASIVE PLAYERS
    PARTICIPANTS
    COMPANY FOOTPRINT: KEY PLAYERS, 2023
    - Company footprint
    - Type footprint
    - Application footprint
    - Component footprint
    - End-user footprint
    - Region footprint
  • 11.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
    PROGRESSIVE COMPANIES
    RESPONSIVE COMPANIES
    DYNAMIC COMPANIES
    STARTING BLOCKS
    COMPETITIVE BENCHMARKING
  • 11.7 BRAND/SOFTWARE COMPARATIVE ANALYSIS
  • 11.8 VALUATION & FINANCIAL METRICS
  • 11.9 COMPETITIVE SCENARIO
    PRODUCT LAUNCHES & APPROVALS
    DEALS
COMPANY PROFILES
309
  • 12.1 KEY PLAYERS
    ORACLE
    - Business overview
    - Products & services offered
    - Recent developments
    - MnM view
    MERATIVE
    - Business overview
    - Products & services offered
    - MnM view
    SAS INSTITUTE INC.
    - Business overview
    - Products & services offered
    - Recent developments
    - MnM view
    ACCENTURE
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    IQVIA INC.
    - Business overview
    - Products & services offered
    - Recent developments
    - MnM view
    COGNIZANT
    - Business overview
    - Products & services offered
    - Recent developments
    WIPRO
    - Business overview
    - Products & services offered
    - Recent developments
    VERADIGM LLC
    - Business overview
    - Products & services offered
    - Recent developments
    OPTUM, INC.
    - Business overview
    - Products & services offered
    - Recent developments
    MICROSOFT
    - Business overview
    - Products & services offered
    - Recent developments
    MAXISIT
    - Business overview
    - Products & services offered
    - Recent developments
    EXLSERVICE HOLDINGS, INC.
    - Business overview
    - Products & services offered
    - Recent developments
    INOVALON
    - Business overview
    - Products & services offered
    - Recent developments
    CITIUSTECH INC.
    - Business overview
    - Products & services offered
    - Recent developments
    SAAMA
    - Business overview
    - Products & services offered
    - Recent developments
    AXTRIA
    - Business overview
    - Products & services offered
    - Recent developments
    CLARIVATE
    - Business overview
    - Products & services offered
    - Recent developments
    THOUGHTSPHERE
    - Business overview
    - Products & services offered
    - Recent developments
    THOUGHTSPOT INC.
    - Business overview
    - Products & services offered
    - Recent developments
    SALESFORCE, INC.
    - Business overview
    - Products & services offered
    - Recent developments
  • 12.2 OTHER PLAYERS
    GOOGLE LLC
    AMAZON WEB SERVICES, INC.
    VEEVA SYSTEMS
    ELSEVIER
    KOMODO HEALTH, INC.
APPENDIX
377
  • 13.1 DISCUSSION GUIDE
  • 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
  • 13.3 CUSTOMIZATION OPTIONS
  • 13.4 RELATED REPORTS
  • 13.5 AUTHOR DETAILS
  • 13.6 TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD
LIST OF TABLES
 
  • TABLE 2 LIFE SCIENCE ANALYTICS MARKET: RISK ASSESSMENT
  • TABLE 3 PHARMACEUTICAL COMPANIES IMPACTED BY CYBERINCIDENTS, 2024
  • TABLE 4 LIFE SCIENCE ANALYTICS MARKET: ROLE IN ECOSYSTEM
  • TABLE 5 LIFE SCIENCE ANALYTICS MARKET: PORTER’S FIVE FORCES
  • TABLE 6 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR END USERS (%)
  • TABLE 7 KEY BUYING CRITERIA FOR END USERS
  • TABLE 8 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 9 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 10 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 11 LATIN AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 12 MIDDLE EAST & AFRICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 13 AVERAGE SELLING PRICE OF LIFE SCIENCE ANALYTICS SOLUTIONS, BY APPLICATION
  • TABLE 14 AVERAGE SELLING PRICE OF ANALYTICS SOLUTIONS, BY REGION
  • TABLE 15 LIFE SCIENCE ANALYTICS MARKET: DETAILED LIST OF CONFERENCES AND EVENTS
  • TABLE 16 LIST OF PATENTS/PATENT APPLICATIONS
  • TABLE 17 UNMET NEEDS IN LIFE SCIENCE ANALYTICS MARKET
  • TABLE 18 END-USER EXPECTATIONS IN LIFE SCIENCE ANALYTICS MARKET
  • TABLE 19 MAJOR INVESTMENTS IN AI IN LIFE SCIENCE ANALYTICS MARKET
  • TABLE 20 LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 21 DESCRIPTIVE ANALYTICS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 22 PREDICTIVE ANALYTICS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 23 PRESCRIPTIVE ANALYTICS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 24 LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
  • TABLE 25 LIFE SCIENCE ANALYTICS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 26 LIFE SCIENCE ANALYTICS SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 27 MANAGED SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 28 MANAGED SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 29 ANALYTICAL SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 30 CONSULTING SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 31 PROFESSIONAL SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 32 PROFESSIONAL SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 33 TRAINING & IMPLEMENTATION SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 34 MAINTENANCE & SUPPORT SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 35 OTHER PROFESSIONAL SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 36 LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 37 LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 38 ON-PREMISE SOLUTIONS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 39 CLOUD-BASED SOLUTIONS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 40 SAAS-BASED SOLUTIONS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 41 LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 42 LIFE SCIENCE ANALYTICS MARKET: COMMERCIALLY AVAILABLE R&D SOLUTIONS
  • TABLE 43 LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH & DEVELOPMENT, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 44 LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH & DEVELOPMENT, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 45 LIFE SCIENCE ANALYTICS MARKET: COMMERCIALLY AVAILABLE CLINICAL TRIAL SOLUTIONS
  • TABLE 46 LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 47 LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 48 LABORATORY SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 49 PATIENT RECRUITMENT SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 50 SITE IDENTIFICATION SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 51 OTHER CLINICAL TRIAL SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 52 LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY PHASE, 2022–2029 (USD MILLION)
  • TABLE 53 PHASE I CLINICAL TRIAL ANALYTICS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 54 PHASE II CLINICAL TRIAL ANALYTICS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 55 PHASE III CLINICAL TRIAL ANALYTICS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 56 LIFE SCIENCE ANALYTICS MARKET: COMMERCIALLY AVAILABLE PRECLINICAL SOLUTIONS
  • TABLE 57 LIFE SCIENCE ANALYTICS MARKET FOR PRECLINICAL & DRUG DISCOVERY, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 58 LIFE SCIENCE ANALYTICS MARKET FOR COMMERCIAL ANALYTICS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 59 LIFE SCIENCE ANALYTICS MARKET FOR COMMERCIAL ANALYTICS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 60 LIFE SCIENCE ANALYTICS MARKET: COMMERCIALLY AVAILABLE SALES & MARKETING SOLUTIONS
  • TABLE 61 LIFE SCIENCE ANALYTICS MARKET FOR SALES & MARKETING SUPPORT, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 62 LIFE SCIENCE ANALYTICS MARKET FOR MARKET ACCESS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 63 LIFE SCIENCE ANALYTICS MARKET FOR RWE & VALUE EVIDENCE, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 64 LIFE SCIENCE ANALYTICS MARKET FOR ENGAGEMENT SERVICES, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 65 LIFE SCIENCE ANALYTICS MARKET: COMMERCIALLY AVAILABLE REGULATORY COMPLIANCE SOLUTIONS
  • TABLE 66 LIFE SCIENCE ANALYTICS MARKET FOR REGULATORY COMPLIANCE, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 67 LIFE SCIENCE ANALYTICS MARKET: COMMERCIALLY AVAILABLE SUPPLY CHAIN OPTIMIZATION SOLUTIONS
  • TABLE 68 LIFE SCIENCE ANALYTICS MARKET FOR MANUFACTURING & SUPPLY CHAIN OPTIMIZATION, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 69 LIFE SCIENCE ANALYTICS MARKET FOR SAFETY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 70 LIFE SCIENCE ANALYTICS MARKET FOR SAFETY, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 71 LIFE SCIENCE ANALYTICS MARKET: COMMERCIALLY AVAILABLE PHARMACOVIGILANCE SOLUTIONS
  • TABLE 72 LIFE SCIENCE ANALYTICS MARKET FOR PHARMACOVIGILANCE, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 73 LIFE SCIENCE ANALYTICS MARKET FOR MEDICAL DEVICE SAFETY, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 74 LIFE SCIENCE ANALYTICS MARKET FOR DIAGNOSTIC VIGILANCE, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 75 LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 76 LIFE SCIENCE ANALYTICS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 77 LIFE SCIENCE ANALYTICS MARKET FOR MEDICAL DEVICE COMPANIES, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 78 LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH CENTERS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 79 LIFE SCIENCE ANALYTICS MARKET FOR OUTSOURCED LIFE SCIENCE ORGANIZATIONS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 80 LIFE SCIENCE ANALYTICS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 81 NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 82 NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 83 NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
  • TABLE 84 NORTH AMERICA: LIFE SCIENCE ANALYTICS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 85 NORTH AMERICA: MANAGED SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 86 NORTH AMERICA: PROFESSIONAL SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 87 NORTH AMERICA: LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 88 NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 89 NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH & DEVELOPMENT, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 90 NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 91 NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY PHASE, 2022–2029 (USD MILLION)
  • TABLE 92 NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET FOR COMMERCIAL ANALYTICS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 93 NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET FOR SAFETY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 94 NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 95 US: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 96 US: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
  • TABLE 97 US: LIFE SCIENCE ANALYTICS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 98 US: MANAGED SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 99 US: PROFESSIONAL SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 100 US: LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 101 US: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 102 US: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH & DEVELOPMENT, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 103 US: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 104 US: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY PHASE, 2022–2029 (USD MILLION)
  • TABLE 105 US: LIFE SCIENCE ANALYTICS MARKET FOR COMMERCIAL ANALYTICS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 106 US: LIFE SCIENCE ANALYTICS MARKET FOR SAFETY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 107 US: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 108 CANADA: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 109 CANADA: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
  • TABLE 110 CANADA: LIFE SCIENCE ANALYTICS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 111 CANADA: MANAGED SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 112 CANADA: PROFESSIONAL SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 113 CANADA: LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 114 CANADA: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 115 CANADA: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH & DEVELOPMENT, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 116 CANADA: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 117 CANADA: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY PHASE, 2022–2029 (USD MILLION)
  • TABLE 118 CANADA: LIFE SCIENCE ANALYTICS MARKET FOR COMMERCIAL ANALYTICS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 119 CANADA: LIFE SCIENCE ANALYTICS MARKET FOR SAFETY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 120 CANADA: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 121 EUROPE: LIFE SCIENCE ANALYTICS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 122 EUROPE: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 123 EUROPE: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
  • TABLE 124 EUROPE: LIFE SCIENCE ANALYTICS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 125 EUROPE: MANAGED SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 126 EUROPE: PROFESSIONAL SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 127 EUROPE: LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 128 EUROPE: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 129 EUROPE: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH & DEVELOPMENT, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 130 EUROPE: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 131 EUROPE: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY PHASE, 2022–2029 (USD MILLION)
  • TABLE 132 EUROPE: LIFE SCIENCE ANALYTICS MARKET FOR COMMERCIAL ANALYTICS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 133 EUROPE: LIFE SCIENCE ANALYTICS MARKET FOR SAFETY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 134 EUROPE: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 135 GERMANY: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 136 GERMANY: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
  • TABLE 137 GERMANY: LIFE SCIENCE ANALYTICS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 138 GERMANY: MANAGED SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 139 GERMANY: PROFESSIONAL SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 140 GERMANY: LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 141 GERMANY: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 142 GERMANY: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH & DEVELOPMENT, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 143 GERMANY: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 144 GERMANY: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY PHASE, 2022–2029 (USD MILLION)
  • TABLE 145 GERMANY: LIFE SCIENCE ANALYTICS MARKET FOR COMMERCIAL ANALYTICS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 146 GERMANY: LIFE SCIENCE ANALYTICS MARKET FOR SAFETY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 147 GERMANY: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 148 FRANCE: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 149 FRANCE: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
  • TABLE 150 FRANCE: LIFE SCIENCE ANALYTICS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 151 FRANCE: MANAGED SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 152 FRANCE: PROFESSIONAL SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 153 FRANCE: LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 154 FRANCE: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 155 FRANCE: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH & DEVELOPMENT, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 156 FRANCE: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 157 FRANCE: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY PHASE, 2022–2029 (USD MILLION)
  • TABLE 158 FRANCE: LIFE SCIENCE ANALYTICS MARKET FOR COMMERCIAL ANALYTICS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 159 FRANCE: LIFE SCIENCE ANALYTICS MARKET FOR SAFETY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 160 FRANCE: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 161 UK: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 162 UK: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
  • TABLE 163 UK: LIFE SCIENCE ANALYTICS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 164 UK: MANAGED SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 165 UK: PROFESSIONAL SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 166 UK: LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 167 UK: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 168 UK: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH & DEVELOPMENT, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 169 UK: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 170 UK: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY PHASE, 2022–2029 (USD MILLION)
  • TABLE 171 UK: LIFE SCIENCE ANALYTICS MARKET FOR COMMERCIAL ANALYTICS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 172 UK: LIFE SCIENCE ANALYTICS MARKET FOR SAFETY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 173 UK: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 174 ITALY: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 175 ITALY: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
  • TABLE 176 ITALY: LIFE SCIENCE ANALYTICS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 177 ITALY: MANAGED SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 178 ITALY: PROFESSIONAL SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 179 ITALY: LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 180 ITALY: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 181 ITALY: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH & DEVELOPMENT, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 182 ITALY: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 183 ITALY: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY PHASE, 2022–2029 (USD MILLION)
  • TABLE 184 ITALY: LIFE SCIENCE ANALYTICS MARKET FOR COMMERCIAL ANALYTICS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 185 ITALY: LIFE SCIENCE ANALYTICS MARKET FOR SAFETY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 186 ITALY: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 187 SPAIN: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 188 SPAIN: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
  • TABLE 189 SPAIN: LIFE SCIENCE ANALYTICS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 190 SPAIN: MANAGED SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 191 SPAIN: PROFESSIONAL SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 192 SPAIN: LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 193 SPAIN: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 194 SPAIN: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH & DEVELOPMENT, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 195 SPAIN: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 196 SPAIN: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY PHASE, 2022–2029 (USD MILLION)
  • TABLE 197 SPAIN: LIFE SCIENCE ANALYTICS MARKET FOR COMMERCIAL ANALYTICS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 198 SPAIN: LIFE SCIENCE ANALYTICS MARKET FOR SAFETY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 199 SPAIN: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 200 REST OF EUROPE: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 201 REST OF EUROPE: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
  • TABLE 202 REST OF EUROPE: LIFE SCIENCE ANALYTICS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 203 REST OF EUROPE: MANAGED SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 204 REST OF EUROPE: PROFESSIONAL SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 205 REST OF EUROPE: LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 206 REST OF EUROPE: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 207 REST OF EUROPE: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH & DEVELOPMENT, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 208 REST OF EUROPE: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 209 REST OF EUROPE: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY PHASE, 2022–2029 (USD MILLION)
  • TABLE 210 REST OF EUROPE: LIFE SCIENCE ANALYTICS MARKET FOR COMMERCIAL ANALYTICS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 211 REST OF EUROPE: LIFE SCIENCE ANALYTICS MARKET FOR SAFETY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 212 REST OF EUROPE: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 213 ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 214 ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 215 ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
  • TABLE 216 ASIA PACIFIC: LIFE SCIENCE ANALYTICS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 217 ASIA PACIFIC: MANAGED SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 218 ASIA PACIFIC: PROFESSIONAL SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 219 ASIA PACIFIC: LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 220 ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 221 ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH & DEVELOPMENT, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 222 ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 223 ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY PHASE, 2022–2029 (USD MILLION)
  • TABLE 224 ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET FOR COMMERCIAL ANALYTICS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 225 ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET FOR SAFETY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 226 ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 227 JAPAN: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 228 JAPAN: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
  • TABLE 229 JAPAN: LIFE SCIENCE ANALYTICS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 230 JAPAN: MANAGED SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 231 JAPAN: PROFESSIONAL SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 232 JAPAN: LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 233 JAPAN: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 234 JAPAN: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH & DEVELOPMENT, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 235 JAPAN: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 236 JAPAN: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY PHASE, 2022–2029 (USD MILLION)
  • TABLE 237 JAPAN: LIFE SCIENCE ANALYTICS MARKET FOR COMMERCIAL ANALYTICS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 238 JAPAN: LIFE SCIENCE ANALYTICS MARKET FOR SAFETY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 239 JAPAN: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 240 CHINA: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 241 CHINA: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
  • TABLE 242 CHINA: LIFE SCIENCE ANALYTICS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 243 CHINA: MANAGED SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 244 CHINA: PROFESSIONAL SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 245 CHINA: LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 246 CHINA: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 247 CHINA: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH & DEVELOPMENT, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 248 CHINA: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 249 CHINA: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY PHASE, 2022–2029 (USD MILLION)
  • TABLE 250 CHINA: LIFE SCIENCE ANALYTICS MARKET FOR COMMERCIAL ANALYTICS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 251 CHINA: LIFE SCIENCE ANALYTICS MARKET FOR SAFETY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 252 CHINA: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 253 INDIA: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 254 INDIA: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
  • TABLE 255 INDIA: LIFE SCIENCE ANALYTICS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 256 INDIA: MANAGED SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 257 INDIA: PROFESSIONAL SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 258 INDIA: LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 259 INDIA: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 260 INDIA: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH & DEVELOPMENT, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 261 INDIA: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 262 INDIA: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY PHASE, 2022–2029 (USD MILLION)
  • TABLE 263 INDIA: LIFE SCIENCE ANALYTICS MARKET FOR COMMERCIAL ANALYTICS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 264 INDIA: LIFE SCIENCE ANALYTICS MARKET FOR SAFETY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 265 INDIA: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 266 REST OF ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 267 REST OF ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
  • TABLE 268 REST OF ASIA PACIFIC: LIFE SCIENCE ANALYTICS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 269 REST OF ASIA PACIFIC: MANAGED SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 270 REST OF ASIA PACIFIC: PROFESSIONAL SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 271 REST OF ASIA PACIFIC: LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 272 REST OF ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 273 REST OF ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH & DEVELOPMENT, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 274 REST OF ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 275 REST OF ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY PHASE, 2022–2029 (USD MILLION)
  • TABLE 276 REST OF ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET FOR COMMERCIAL ANALYTICS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 277 REST OF ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET FOR SAFETY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 278 REST OF ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 279 LATIN AMERICA: LIFE SCIENCE ANALYTICS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 280 LATIN AMERICA: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 281 LATIN AMERICA: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
  • TABLE 282 LATIN AMERICA: LIFE SCIENCE ANALYTICS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 283 LATIN AMERICA: MANAGED SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 284 LATIN AMERICA: PROFESSIONAL SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 285 LATIN AMERICA: LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 286 LATIN AMERICA: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 287 LATIN AMERICA: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH & DEVELOPMENT, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 288 LATIN AMERICA: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 289 LATIN AMERICA: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY PHASE, 2022–2029 (USD MILLION)
  • TABLE 290 LATIN AMERICA: LIFE SCIENCE ANALYTICS MARKET FOR COMMERCIAL ANALYTICS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 291 LATIN AMERICA: LIFE SCIENCE ANALYTICS MARKET FOR SAFETY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 292 LATIN AMERICA: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 293 BRAZIL: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 294 BRAZIL: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
  • TABLE 295 BRAZIL: LIFE SCIENCE ANALYTICS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 296 BRAZIL: MANAGED SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 297 BRAZIL: PROFESSIONAL SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 298 BRAZIL: LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 299 BRAZIL: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 300 BRAZIL: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH & DEVELOPMENT, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 301 BRAZIL: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 302 BRAZIL: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY PHASE, 2022–2029 (USD MILLION)
  • TABLE 303 BRAZIL: LIFE SCIENCE ANALYTICS MARKET FOR COMMERCIAL ANALYTICS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 304 BRAZIL: LIFE SCIENCE ANALYTICS MARKET FOR SAFETY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 305 BRAZIL: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 306 MEXICO: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 307 MEXICO: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
  • TABLE 308 MEXICO: LIFE SCIENCE ANALYTICS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 309 MEXICO: MANAGED SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 310 MEXICO: PROFESSIONAL SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 311 MEXICO: LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 312 MEXICO: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 313 MEXICO: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH & DEVELOPMENT, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 314 MEXICO: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 315 MEXICO: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY PHASE, 2022–2029 (USD MILLION)
  • TABLE 316 MEXICO: LIFE SCIENCE ANALYTICS MARKET FOR COMMERCIAL ANALYTICS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 317 MEXICO: LIFE SCIENCE ANALYTICS MARKET FOR SAFETY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 318 MEXICO: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 319 REST OF LATIN AMERICA: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 320 REST OF LATIN AMERICA: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
  • TABLE 321 REST OF LATIN AMERICA: LIFE SCIENCE ANALYTICS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 322 REST OF LATIN AMERICA: MANAGED SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 323 REST OF LATIN AMERICA: PROFESSIONAL SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 324 REST OF LATIN AMERICA: LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 325 REST OF LATIN AMERICA: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 326 REST OF LATIN AMERICA: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH & DEVELOPMENT, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 327 REST OF LATIN AMERICA: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 328 REST OF LATIN AMERICA: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY PHASE, 2022–2029 (USD MILLION)
  • TABLE 329 REST OF LATIN AMERICA: LIFE SCIENCE ANALYTICS MARKET FOR COMMERCIAL ANALYTICS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 330 REST OF LATIN AMERICA: LIFE SCIENCE ANALYTICS MARKET FOR SAFETY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 331 REST OF LATIN AMERICA: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 332 MIDDLE EAST & AFRICA: LIFE SCIENCE ANALYTICS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 333 MIDDLE EAST & AFRICA: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 334 MIDDLE EAST & AFRICA: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
  • TABLE 335 MIDDLE EAST & AFRICA: LIFE SCIENCE ANALYTICS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 336 MIDDLE EAST & AFRICA: MANAGED SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 337 MIDDLE EAST & AFRICA: PROFESSIONAL SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 338 MIDDLE EAST & AFRICA: LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 339 MIDDLE EAST & AFRICA: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 340 MIDDLE EAST & AFRICA: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH & DEVELOPMENT, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 341 MIDDLE EAST & AFRICA: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 342 MIDDLE EAST & AFRICA: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY PHASE, 2022–2029 (USD MILLION)
  • TABLE 343 MIDDLE EAST & AFRICA: LIFE SCIENCE ANALYTICS MARKET FOR COMMERCIAL ANALYTICS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 344 MIDDLE EAST & AFRICA: LIFE SCIENCE ANALYTICS MARKET FOR SAFETY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 345 MIDDLE EAST & AFRICA: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 346 GCC COUNTRIES: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 347 GCC COUNTRIES: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
  • TABLE 348 GCC COUNTRIES: LIFE SCIENCE ANALYTICS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 349 GCC COUNTRIES: MANAGED SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 350 GCC COUNTRIES: PROFESSIONAL SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 351 GCC COUNTRIES: LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 352 GCC COUNTRIES: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 353 GCC COUNTRIES: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH & DEVELOPMENT, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 354 GCC COUNTRIES: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 355 GCC COUNTRIES: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY PHASE, 2022–2029 (USD MILLION)
  • TABLE 356 GCC COUNTRIES: LIFE SCIENCE ANALYTICS MARKET FOR COMMERCIAL ANALYTICS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 357 GCC COUNTRIES: LIFE SCIENCE ANALYTICS MARKET FOR SAFETY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 358 GCC COUNTRIES: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 359 REST OF MIDDLE EAST & AFRICA: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 360 REST OF MIDDLE EAST & AFRICA: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
  • TABLE 361 REST OF MIDDLE EAST & AFRICA: LIFE SCIENCE ANALYTICS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 362 REST OF MIDDLE EAST & AFRICA: MANAGED SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 363 REST OF MIDDLE EAST & AFRICA: PROFESSIONAL SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 364 REST OF MIDDLE EAST & AFRICA: LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 365 REST OF MIDDLE EAST & AFRICA: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 366 REST OF MIDDLE EAST & AFRICA: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH & DEVELOPMENT, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 367 REST OF MIDDLE EAST & AFRICA: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 368 REST OF MIDDLE EAST & AFRICA: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY PHASE, 2022–2029 (USD MILLION)
  • TABLE 369 REST OF MIDDLE EAST & AFRICA: LIFE SCIENCE ANALYTICS MARKET FOR COMMERCIAL ANALYTICS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 370 REST OF MIDDLE EAST & AFRICA: LIFE SCIENCE ANALYTICS MARKET FOR SAFETY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 371 REST OF MIDDLE EAST & AFRICA: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 372 LIFE SCIENCE ANALYTICS MARKET: DEGREE OF COMPETITION
  • TABLE 373 LIFE SCIENCE ANALYTICS MARKET: TYPE FOOTPRINT (25 COMPANIES)
  • TABLE 374 LIFE SCIENCE ANALYTICS MARKET: APPLICATION FOOTPRINT (25 COMPANIES)
  • TABLE 375 LIFE SCIENCE ANALYTICS MARKET: COMPONENT FOOTPRINT (25 COMPANIES)
  • TABLE 376 LIFE SCIENCE ANALYTICS MARKET: END-USER FOOTPRINT (25 COMPANIES)
  • TABLE 377 LIFE SCIENCE ANALYTICS MARKET: REGION FOOTPRINT (25 COMPANIES)
  • TABLE 378 LIFE SCIENCE ANALYTICS MARKET: DETAILED LIST OF KEY STARTUPS/SMES
  • TABLE 379 LIFE SCIENCE ANALYTICS MARKET: COMPETITIVE BENCHMARKING OF KEY PLAYERS (STARTUPS/SMES)
  • TABLE 380 LIFE SCIENCE ANALYTICS MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–SEPTEMBER 2024
  • TABLE 381 LIFE SCIENCE ANALYTICS MARKET: DEALS, JANUARY 2021–SEPTEMBER 2024
  • TABLE 382 ORACLE: COMPANY OVERVIEW
  • TABLE 383 ORACLE: PRODUCTS & SERVICES OFFERED
  • TABLE 384 ORACLE: DEALS, JANUARY 2021–SEPTEMBER 2024
  • TABLE 385 MERATIVE: COMPANY OVERVIEW
  • TABLE 386 MERATIVE: PRODUCTS & SERVICES OFFERED
  • TABLE 387 MERATIVE: DEALS, JANUARY 2021–SEPTEMBER 2024
  • TABLE 388 SAS INSTITUTE: COMPANY OVERVIEW
  • TABLE 389 SAS INSTITUTE: PRODUCTS & SERVICES OFFERED
  • TABLE 390 SAS INSTITUTE: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–SEPTEMBER 2024
  • TABLE 391 SAS INSTITUTE: DEALS, JANUARY 2021–SEPTEMBER 2024
  • TABLE 392 ACCENTURE: COMPANY OVERVIEW
  • TABLE 393 ACCENTURE: PRODUCTS OFFERED
  • TABLE 394 ACCENTURE: DEALS, JANUARY 2021–SEPTEMBER 2024
  • TABLE 395 IQVIA: COMPANY OVERVIEW
  • TABLE 396 IQVIA: PRODUCTS & SERVICES OFFERED
  • TABLE 397 IQVIA: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–SEPTEMBER 2024
  • TABLE 398 IQVIA: DEALS, JANUARY 2021–SEPTEMBER 2024
  • TABLE 399 IQVIA: OTHER DEVELOPMENTS, JANUARY 2021–SEPTEMBER 2024
  • TABLE 400 COGNIZANT: COMPANY OVERVIEW
  • TABLE 401 COGNIZANT: PRODUCTS & SERVICES OFFERED
  • TABLE 402 COGNIZANT: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–SEPTEMBER 2024
  • TABLE 403 COGNIZANT: DEALS, JANUARY 2021–SEPTEMBER 2024
  • TABLE 404 WIPRO: COMPANY OVERVIEW
  • TABLE 405 WIPRO: PRODUCTS & SERVICES OFFERED
  • TABLE 406 WIPRO: DEALS, JANUARY 2021–SEPTEMBER 2024
  • TABLE 407 VERADIGM: COMPANY OVERVIEW
  • TABLE 408 VERADIGM: PRODUCTS & SERVICES OFFERED
  • TABLE 409 VERADIGM: DEALS, JANUARY 2021–SEPTEMBER 2024
  • TABLE 410 OPTUM: COMPANY OVERVIEW
  • TABLE 411 OPTUM: PRODUCTS & SERVICES OFFERED
  • TABLE 412 OPTUM: DEALS, JANUARY 2021–SEPTEMBER 2024
  • TABLE 413 MICROSOFT: COMPANY OVERVIEW
  • TABLE 414 MICROSOFT: PRODUCTS & SERVICES OFFERED
  • TABLE 415 MICROSOFT: PRODUCT & SERVICE LAUNCHES & ENHANCEMENTS, JANUARY 2021–SEPTEMBER 2024
  • TABLE 416 MICROSOFT: DEALS, JANUARY 2021–SEPTEMBER 2024
  • TABLE 417 MAXISIT: COMPANY OVERVIEW
  • TABLE 418 MAXISIT: PRODUCTS & SERVICES OFFERED
  • TABLE 419 MAXISIT: PRODUCT LAUNCHES, JANUARY 2021–SEPTEMBER 2024
  • TABLE 420 MAXISIT: DEALS, JANUARY 2021–SEPTEMBER 2024
  • TABLE 421 EXLSERVICE HOLDINGS: COMPANY OVERVIEW
  • TABLE 422 EXLSERVICE HOLDINGS: PRODUCTS & SERVICES OFFERED
  • TABLE 423 EXLSERVICE HOLDINGS: PRODUCT LAUNCHES, JANUARY 2021–SEPTEMBER 2024
  • TABLE 424 EXLSERVICE HOLDINGS: DEALS, JANUARY 2021–SEPTEMBER 2024
  • TABLE 425 INOVALON: COMPANY OVERVIEW
  • TABLE 426 INOVALON: PRODUCTS & SERVICES OFFERED
  • TABLE 427 INOVALON: PRODUCT LAUNCHES, JANUARY 2021–SEPTEMBER 2024
  • TABLE 428 INOVALON: DEALS, JANUARY 2021–SEPTEMBER 2024
  • TABLE 429 CITIUSTECH: COMPANY OVERVIEW
  • TABLE 430 CITIUSTECH: PRODUCTS & SERVICES OFFERED
  • TABLE 431 CITIUSTECH: PRODUCT LAUNCHES, JANUARY 2021–SEPTEMBER 2024
  • TABLE 432 CITIUSTECH: DEALS, JANUARY 2021–SEPTEMBER 2024
  • TABLE 433 CITIUSTECH: EXPANSIONS, JANUARY 2021–SEPTEMBER 2024
  • TABLE 434 SAAMA: COMPANY OVERVIEW
  • TABLE 435 SAAMA: PRODUCTS & SERVICES OFFERED
  • TABLE 436 SAAMA: DEALS, JANUARY 2021–SEPTEMBER 2024
  • TABLE 437 AXTRIA: COMPANY OVERVIEW
  • TABLE 438 AXTRIA: PRODUCTS & SERVICES OFFERED
  • TABLE 439 AXTRIA: PRODUCT LAUNCHES, JANUARY 2021–SEPTEMBER 2024
  • TABLE 440 AXTRIA: DEALS, JANUARY 2021–SEPTEMBER 2024
  • TABLE 441 AXTRIA: EXPANSIONS, JANUARY 2021–SEPTEMBER 2024
  • TABLE 442 CLARIVATE: COMPANY OVERVIEW
  • TABLE 443 CLARIVATE: PRODUCTS & SERVICES OFFERED
  • TABLE 444 CLARIVATE: PRODUCT ENHANCEMENTS, JANUARY 2021–SEPTEMBER 2024
  • TABLE 445 CLARIVATE: DEALS, JANUARY 2021–SEPTEMBER 2024
  • TABLE 446 THOUGHTSPHERE: COMPANY OVERVIEW
  • TABLE 447 THOUGHTSPHERE.: PRODUCTS & SERVICES OFFERED
  • TABLE 448 THOUGHTSPHERE.: DEALS, JANUARY 2021–SEPTEMBER 2024
  • TABLE 449 THOUGHTSPOT: COMPANY OVERVIEW
  • TABLE 450 THOUGHTSPOT: PRODUCTS & SERVICES OFFERED
  • TABLE 451 THOUGHTSPOT: DEALS, JANUARY 2021–SEPTEMBER 2024
  • TABLE 452 THOUGHTSPOT: EXPANSIONS, JANUARY 2021–SEPTEMBER 2024
  • TABLE 453 SALESFORCE: COMPANY OVERVIEW
  • TABLE 454 SALESFORCE: PRODUCTS & SERVICES OFFERED
  • TABLE 455 SALESFORCE: DEALS, JANUARY 2021–SEPTEMBER 2024
  • FIGURE 1 RESEARCH DESIGN
LIST OF FIGURES
 
  • FIGURE 2 PRIMARY SOURCES
  • FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 4 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
  • FIGURE 5 LIFE SCIENCE ANALYTICS MARKET: REVENUE SHARE ANALYSIS ILLUSTRATION
  • FIGURE 6 BOTTOM-UP APPROACH: END-USER SPENDING ON LIFE SCIENCE ANALYTICS
  • FIGURE 7 LIFE SCIENCE ANALYTICS MARKET: CAGR PROJECTION FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2024–2029)
  • FIGURE 8 CAGR PROJECTION: SUPPLY-SIDE ANALYSIS
  • FIGURE 9 TOP-DOWN APPROACH
  • FIGURE 10 DATA TRIANGULATION METHODOLOGY
  • FIGURE 11 LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION)
  • FIGURE 12 LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2024 VS. 2029 (USD MILLION)
  • FIGURE 13 LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION)
  • FIGURE 14 LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)
  • FIGURE 15 LIFE SCIENCE ANALYTICS MARKET: GEOGRAPHICAL SNAPSHOT
  • FIGURE 16 RISING TECHNOLOGICAL ADVANCEMENTS AND GROWING ADOPTION OF ANALYTICS SOLUTIONS FOR CLINICAL TRIALS TO DRIVE MARKET
  • FIGURE 17 NORTH AMERICA TO DOMINATE LABORATORY INFORMATICS MARKET DURING FORECAST PERIOD
  • FIGURE 18 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES IN NORTH AMERICA ACCOUNTED FOR LARGEST MARKET SHARE IN 2023
  • FIGURE 19 CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
  • FIGURE 20 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD
  • FIGURE 21 LIFE SCIENCE ANALYTICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 22 HEALTH EXPENDITURE AS SHARE OF GDP, 2022 (OR NEAREST YEAR)
  • FIGURE 23 LIFE SCIENCE ANALYTICS MARKET ECOSYSTEM
  • FIGURE 24 LIFE SCIENCE ANALYTICS MARKET: VALUE CHAIN ANALYSIS
  • FIGURE 25 LIFE SCIENCE ANALYTICS MARKET: PORTER’S FIVE FORCES ANALYSIS
  • FIGURE 26 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR END USERS
  • FIGURE 27 KEY BUYING CRITERIA FOR END USERS
  • FIGURE 28 REVENUE SHIFT IN LIFE SCIENCE ANALYTICS MARKET
  • FIGURE 29 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR “LIFE SCIENCE ANALYTICS” PATENTS, JANUARY 2011–SEPTEMBER 2024
  • FIGURE 30 MAJOR PATENTS FOR LIFE SCIENCE ANALYTICS (JANUARY 2011- SEPTEMBER 2024)
  • FIGURE 31 FUNDING OF PLAYERS IN LIFE SCIENCE ANALYTICS MARKET
  • FIGURE 32 MARKET POTENTIAL OF AI/GENERATIVE AI, BY INDUSTRY
  • FIGURE 33 IMPACT OF GEN AI ON INTERCONNECTED AND ADJACENT ECOSYSTEMS
  • FIGURE 34 NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET SNAPSHOT
  • FIGURE 35 ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET SNAPSHOT
  • FIGURE 36 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN LIFE SCIENCE ANALYTICS MARKET
  • FIGURE 37 REVENUE ANALYSIS OF KEY PLAYERS IN LIFE SCIENCE ANALYTICS MARKET (2019–2023)
  • FIGURE 38 LIFE SCIENCE ANALYTICS MARKET: MARKET SHARE ANALYSIS (2023)
  • FIGURE 39 LIFE SCIENCE ANALYTICS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
  • FIGURE 40 LIFE SCIENCE ANALYTICS MARKET: COMPANY FOOTPRINT (25 COMPANIES)
  • FIGURE 41 LIFE SCIENCE ANALYTICS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
  • FIGURE 42 EV/EBITDA OF KEY VENDORS
  • FIGURE 43 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF LIFE SCIENCE ANALYTICS VENDORS
  • FIGURE 44 ORACLE: COMPANY SNAPSHOT (2023)
  • FIGURE 45 ACCENTURE: COMPANY SNAPSHOT (2023)
  • FIGURE 46 IQVIA: COMPANY SNAPSHOT (2023)
  • FIGURE 47 COGNIZANT: COMPANY SNAPSHOT (2023)
  • FIGURE 48 WIPRO: COMPANY SNAPSHOT (2023)
  • FIGURE 49 VERADIGM: COMPANY SNAPSHOT (2023)
  • FIGURE 50 UNITED HEALTH GROUP: COMPANY SNAPSHOT (2023)
  • FIGURE 51 MICROSOFT: COMPANY SNAPSHOT (2023)
  • FIGURE 52 EXLSERVICE HOLDINGS: COMPANY SNAPSHOT (2023)
  • FIGURE 53 CLARIVATE: COMPANY SNAPSHOT (2023)
  • FIGURE 54 SALESFORCE: COMPANY SNAPSHOT (2023)

The study involved significant activities to estimate the current size of the life science analytics market. Exhaustive secondary research was done to collect information on the life science analytics market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain using primary research. Different approaches, such as top-down and bottom-up, were employed to estimate the total market size. After that, the market breakup and data triangulation procedures were used to estimate the market size of the segments and subsegments of the life science analytics market.

Secondary Research

This research study involved the wide use of secondary sources, directories, and databases such as Dun & Bradstreet, Bloomberg Businessweek, and Factiva; white papers, annual reports, and companies’ house documents; investor presentations; and the SEC filings of companies. The market for the companies offering life science analytics solutions is arrived at by secondary data available through paid and unpaid sources, analyzing the product portfolios of the major companies in the ecosystem, and rating the companies by their performance and quality. Various sources were referred to in the secondary research process to identify and collect information for this study. The secondary sources include annual reports, press releases, investor presentations of companies, white papers, journals, certified publications, and articles from recognized authors, directories, and databases.

Various secondary sources were referred to in the secondary research process to identify and collect information related to the study. These sources included annual reports, press releases, investor presentations of life science analytics vendors, forums, certified publications, and whitepapers. The secondary research was used to obtain critical information on the industry’s value chain, the total pool of key players, market classification, and segmentation from the market and technology-oriented perspectives.

Primary Research

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Primary sources are mainly industry experts from the core and related industries and preferred suppliers, manufacturers, distributors, technology developers, researchers, and organizations related to all segments of this industry’s value chain. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among other experts, to obtain and verify the critical qualitative and quantitative information as well as assess prospects.

Primary research was conducted to identify segmentation types; industry trends; key players; and key market dynamics such as drivers, restraints, opportunities, challenges, industry trends, and strategies adopted by key players.

After the complete market engineering (calculations for market statistics, market breakdown, market size estimations, market forecasting, and data triangulation), extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. Primary research was also undertaken to identify the segmentation types, industry trends, competitive landscape of life science analytics solutions offered by various market players, and key market dynamics, such as drivers, restraints, opportunities, challenges, industry trends, and key player strategies.

In the complete market engineering process, the top-down and bottom-up approaches and several data triangulation methods were extensively used to perform the market estimation and market forecasting for the overall market segments and subsegments listed in this report. Extensive qualitative and quantitative analysis was performed on the complete market engineering process to list the key information/insights throughout the report.

Breakdown of the Primary Respondents:

*Others include sales managers, marketing managers, and product managers.

Note: Tiers are defined based on a company’s total revenue, as of 2023: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = < USD 500 million.

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

The market size estimates and forecasts provided in this study are derived through a mix of the bottom-up approach (revenue share analysis of leading players) and top-down approach (assessment of utilization/adoption/penetration trends, by type, component, application, end user, and region).

Data Triangulation

After arriving at the overall market size—using the market size estimation processes—the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and sub-segment, the data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the life science analytics market.

Market Definition

Life science analytics is the efficient use of data and related business insights developed through statistical, quantitative, predictive, comparative, cognitive, and other emerging applied analytical models. Life science analytics tools help reveal and understand historical data patterns, predict future outcomes, and provide actionable insights to drive fact-based decision-making for improved performance of life science organizations.

Stakeholders

  • Pharmaceutical and biotechnology companies
  • Medical device companies
  • Contract research organizations (CROs)
  • Life science analytics vendors
  • Platform providers
  • Technology providers
  • System integrators
  • Healthcare IT service providers
  • Forums, alliances, and associations
  • Distributors
  • Government organizations
  • Academic research institutes
  • Institutional investors and investment banks
  • Investors/Shareholders
  • Venture capitalists
  • Research and consulting firms

Report Objectives

  • To define, describe, and forecast the global Life science analytics market based on type, component, application, end user, and region
  • To provide detailed information regarding the factors influencing the growth of the market (such as the drivers, restraints, opportunities, and challenges)
  • To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall life science analytics market
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for market leaders
  • To forecast the size of the life science analytics market in five main regions (along with their respective key countries): North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
  • To profile key players and comprehensively analyze their product portfolios, market positions, and core competencies in the market
  • To track and analyze competitive developments such as product & service launches; expansions; partnerships, agreements, and collaborations; and acquisitions in the life science analytics market
  • To benchmark players within the life science analytics market using the Company Evaluation Matrix framework, which analyzes market players on various parameters within the broad categories of business strategy, market share, and product offering

Previous Versions of this Report

Life Science Analytics Market by Type (Predictive, Descriptive, Prescriptive), Application (Sales & Marketing, Regulatory Compliance, R&D, Pharmacovigilance), Component (Software, Service), Delivery (On Premise, On Demand), End User & Region - Global Forecast to 2027

Report Code HIT 4869
Published in Oct, 2024, By MarketsandMarkets™

Life Science Analytics Market by Type (Predictive, Descriptive, Prescriptive), Application (Marketing, Compliance, Clinical trial, R&D, Pharmacovigilance, SCM), Component (Software, Service), Delivery, End User, Region - Global Forecasts to 2025

Report Code HIT 4869
Published in Feb, 2023, By MarketsandMarkets™

Life Science Analytics Market by Type (Predictive, Descriptive, Prescriptive), Application (Marketing, Compliance, Clinical trial, R&D, Pharmacovigilance, SCM), Component (Software, Service), Delivery, End User, Region - Global Forecast to 2025

Report Code HIT 4869
Published in Sep, 2020, By MarketsandMarkets™

Life Science Analytics Market by Type (Predictive, Descriptive, Prescriptive), Application (Marketing, Compliance, R&D, Pharmacovigilance, SCM), Component (Software, Service), Delivery (On Premise, Cloud), End User - Global Forecast to 2024

Report Code HIT 4869
Published in Jul, 2019, By MarketsandMarkets™

Life Science Analytics Market by Type (Predictive, Descriptive, Prescriptive), Application (Marketing, Compliance, R&D, Pharmacovigilance, SCM), Component (Software, Service), Delivery (On Premise, Cloud), End User - Global Forecast to 2024

Report Code HIT 4869
Published in Jan, 2017, By MarketsandMarkets™

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements

Get 10% Free Customisation

Growth opportunities and latent adjacency in Life Science Analytics Market

DMCA.com Protection Status